Sarah E. Ackermann

机构：University of North Carolina at Chapel Hill, Cornell University, Weill Cornell Medicine · ORCID：0000-0002-6898-7361

发表论文 144 篇 · 总被引 652 次 · h-index 9

代表论文

• Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities (2026 · Science Advances · 被引 1)
• Abstract A047: Mechanistic dissection and inhibitor targeting of nutrient scavenging in pancreatic cancer (2026 · Cancer Research)
• Survivin Promotes the Formation of a Microtubule-Based Glycolytic Hub (2026 · bioRxiv (Cold Spring Harbor Laboratory))
• Figure 1 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling (2026)
• Figure 3 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling (2026)
• Figure 4 from Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling (2026)